Chronic Obstructive Pulmonary Disease (COPD)

This module discusses the 2018 GOLD guidelines for COPD, which are significantly different from the previously used NICE guidelines in that more focus is given to symptom control rather than deciding treatment based purely on the FEV1 value. The module focuses on the practical applications of these guidelines, giving audit ideas to find patients with undiagnosed COPD and ensure that treatment is up to date and evidence based. 

An educational grant was received by Pfizer Limited for the production of the course.  Editorial and content decisions were made solely by the RCGP.